Nevertheless, pharmacogenetic effects of angiotensin-converting enzyme inhibitors over the age-related decline in renal function have never been studied before, even though they seem to boost genetically mediated neuroprotective effects in dementia due to Alzheimer disease 5 while also benefitting learning abilities in healthy older individuals 12. The gene discussed is ACE; the disease is Alzheimer disease.